Home Other Building Blocks 52050-17-6
52050-17-6,MFCD00079314
Catalog No.:AA00DF1K

52050-17-6 | GLUCOPSYCHOSINE

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$149.00   $104.00
- +
5mg
≥98%
in stock  
$436.00   $305.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00DF1K
Chemical Name:
GLUCOPSYCHOSINE
CAS Number:
52050-17-6
Molecular Formula:
C24H47NO7
Molecular Weight:
461.6325
MDL Number:
MFCD00079314
SMILES:
CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)N)O
Properties
Properties
 
Form:
Solid  
MP:
>136°C (dec.)  
Storage:
Keep in dry area;-20 ℃;Inert atmosphere;  

Computed Properties
 
Complexity:
479  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
7  
Defined Bond Stereocenter Count:
1  
Heavy Atom Count:
32  
Hydrogen Bond Acceptor Count:
8  
Hydrogen Bond Donor Count:
6  
Rotatable Bond Count:
18  
XLogP3:
3.7  

Literature

Title: Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation.

Journal: American journal of hematology 20120401

Title: Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease.

Journal: The Journal of biological chemistry 20120203

Title: Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.

Journal: PloS one 20120101

Title: Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.

Journal: Blood 20111020

Title: Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples.

Journal: Neurochemical research 20110901

Title: Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.

Journal: Molecular genetics and metabolism 20110401

Title: How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?

Journal: Clinica chimica acta; international journal of clinical chemistry 20101214

Title: Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits.

Journal: Human molecular genetics 20100315

Title: A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.

Journal: Journal of dermatological science 20090701

Title: Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation.

Journal: Journal of pharmacological sciences 20051001

Title: Sphingolipids as bioactive regulators of thrombin generation.

Journal: The Journal of biological chemistry 20040326

Title: Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3.

Journal: Neurobiology of disease 20031201

Title: Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms.

Journal: The Biochemical journal 20031101

Title: Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride.

Journal: Journal of lipid research 20030701

Title: Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms.

Journal: The Journal of biological chemistry 20030627

Title: Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?

Journal: Molecular genetics and metabolism 20030601

Title: Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup.

Journal: Pediatric research 20030301

Title: Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis.

Journal: Laboratory investigation; a journal of technical methods and pathology 20030301

Title: Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis.

Journal: Journal of lipid research 20030101

Title: Glucosylceramide modulates membrane traffic along the endocytic pathway.

Journal: Journal of lipid research 20021101

Title: Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine.

Journal: Neuroscience letters 20020920

Title: Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.

Journal: Molecular genetics and metabolism 20020801

Title: Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations.

Journal: Journal of lipid research 20010801

Title: Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats.

Journal: British journal of pharmacology 20010401

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:52050-17-6 Molecular Formula|52050-17-6 MDL|52050-17-6 SMILES|52050-17-6 GLUCOPSYCHOSINE